Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 · clinicaltrials.gov ↗
COMPLETED
Status
605
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer